sábado, 29 de octubre de 2011

Data Points Publication Series - Series Overview | AHRQ Effective Health Care Program

New Data Points Reports Available on Anticancer Biologic Products Among Medicare Beneficiaries
Two new Data Points reports on anticancer biologic products among Medicare beneficiaries are available from AHRQ’s Effective Health Care Program.  Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009, examines utilization and costs of the anticancer biologics within Medicare Parts A, B, and D claims: monoclonal antibodies, kinase inhibitors, biologic response modifiers, other immunomodulators, other immu­nosuppressives, and miscellaneous biologic nonblood products.   Data Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009, examines the types of cancer for which anticancer biologics are used, as identified in Medicare Parts B and D claims.  This continuing series of reports, published by the DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) Network provides new information and insights into the use of health care services and interventions for the treatment, management, and diagnosis of specific diseases. It also highlights the variations and potential disparities in health care services across patient subpopulations. Select to access these Data Points reports.

Data Points Publication Series - Series Overview AHRQ Effective Health Care Program


Data Points Publication Series

This continuing series of reports, published by the DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) Network provides new information and insights into the use of health care services and interventions for the treatment, management, and diagnosis of specific diseases, it also highlights the variations and potential disparities in health care services across patient subpopulations. The reports provide brief descriptive statistics, background information, and analytic tables on a variety of specific, focused topics. Certain reports will present new statistics on topics such as disease incidence, prevalence, and burden of illness and outcomes such as hospital readmission, morbidity, and mortality. The series reports will generally summarize the basic demographic and geographic breakdowns of the data, with additional details provided in statistical tables that can be downloaded from this Web site.
Overall, the report series will assist stakeholders in describing important trends in health care and in identifying research questions for new studies on comparative effectiveness and patient-centered outcomes. Researchers from the DEcIDE Network will initially use existing health care databases, particularly those available from the Federal Medicare program, to produce the reports.

Published Reports

Data Points #1: Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006-2008 (PDF) 2.6 MB.
Additional tables: Select for Excel File (82 kB), or PDF (374 kB).
Data Points #2: Incidence of diabetic foot ulcer and lower extremity amputation among Medicare beneficiaries, 2006-2008 (PDF) 2.7 MB.
Additional tables: Select for Excel File (107 kB), or PDF (520 kB).
Data Points #3: Economic burden of diabetic foot ulcers and amputations (PDF) 619 kB.
Additional tables: Select for Excel File (999 kB), or PDF (5.7 MB).
Data Points #4: Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease (PDF) 344 kB.
Data Points #5: Prevalence and Medicare reimbursement by recurrent international classification of diseases categories, 2006-2009 (PDF) 581 kB.
Visit the Web page of this report to access additional tables and maps.
Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 (PDF) 1.46 MB.
Visit the Web page of this report to access additional tables and maps.
Date Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009 (PDF) 1.74 MB.
Additional Tables: Select for Excel File (159 kB), or PDF (991 kB).

No hay comentarios: